How Humans Evolved a Starch-Digesting Superpower Long Before Farming

Picture of Patrick Wang

Patrick Wang

Expert of Peptides | Ask me anything about Peptides | Sales Manager at AHB Lab
cover

Table of Contents

If you’ve ever felt a rush of energy after consuming a thick slice of bread or a roasted yam, you should be thankful for an amazing genetic mutation that occurred in our ancestors hundreds of thousands of years ago. Recent research has uncovered how humans evolved to become better starch digesters and how such an evolutionary trait, as it would turn out, actually predates the birth of agriculture by a long shot.

Indeed, two landmark studies-one in Nature and the other in Science-shed light on how the gene responsible for digestion of starch, AMY1, has evolved. This gene helps in the production of the enzyme amylase, which acts on starch in our mouth and breaks it down to sugars. Investigations not only delve into when this gene first duplicated but also reveal how the rise of agriculture has massively influenced its evolution.

 

The Starch-Digesting Gene: AMY1

The gene responsible for salivary amylase, AMY1, begins the digestion of starch by producing amylase in the saliva. Modern humans have multiple copies of this gene, and populations with high-starch diets-whether from grains or tubers-tend to have even more copies. This allows them to extract even more energy out of starchy foods; this trait has doubtlessly played a key role in survival within a population.

Until now, however, the origins of this gene duplication, and why AMY1 has become so prone to multiple copies, had remained unresolved. The following recent studies add a great deal to the previous knowledge about the timing of duplication and its genetic mechanism, therefore unraveling the evolutionary journey of starch-digestive capabilities in humans.

 

The Evolution of AMY1: Conflicting Timelines

While the two studies agree on the general outlines of how AMY1 evolved, they disagree on precisely when the gene first duplicated. Using one of the studies, from Peter Sudmant of the University of California, Berkeley, the gene duplication is pegged at roughly 279,000 years ago, long before agriculture took root. The other, led by Charles Lee from the Jackson Laboratory and Omer Gokcumen from the University at Buffalo, offers an even earlier timeline: perhaps the gene duplicated as long ago as 800,000 years.

That’s a striking difference, yet it does nothing to contradict the central findings: both studies confirm that agriculture’s rise did indeed affect the number of AMY1 copies found in modern-day humans.

 

Agriculture and the Surge of AMY1

Agriculture, which began around 12,000 years ago, turned wheat, yams, and rice into food staples. As these starch-rich crops became more common, people who carried extra copies of the AMY1 gene were better adapted to digesting starch and absorbing nutrition from them. In essence, the shift toward agricultural diets triggered an explosive proliferation of AMY1 gene copies in successive generations, both teams report.

The Sudmant-led study examined the genomes of 519 ancient Eurasians to go back 12,000 years. The team believed that an average of four to over seven copies of AMY1 per person increased about 5,000 years ago when agriculture spread across Europe and Asia. The increased copy number of AMY1 was a striking example of natural selection for the ability to convert starch into energy more efficiently, which helped early individuals survive and reproduce in agrarian societies.

 

Neanderthals and Denisovans: Did They Have AMY1 Duplications?

The question for the research was whether human relatives such as Neanderthals and Denisovans also carried multiple copies of the AMY1 gene. As these new studies explain, the answer is complicated.

However, Sudmant’s team found no evidence of duplicated copies of the gene in the genomes of three Neanderthals and one Denisovan. By contrast, the work of Lee and Gokcumen indicates another scenario: duplications of the gene AMY1 in some Neanderthals and Denisovans. This would suggest either that the gene duplications occurred far earlier than previously thought, or that those ancient relatives had acquired the gene copies through interbreeding with modern humans.

Whatever the exact timing, it is clear that AMY1 duplications have been a part of the human genome for a long period and such gene copies most probably played an important role in enabling early humans and their relatives to adapt to different dietary environments.

 

Why is AMY1 So Prone to Duplication?

One of the big contributions of the new studies is to explain how easily the AMY1 gene duplicates. The work by Lee and Gokcumen shows that once a specific version of the gene-a “three-copy haplotype”-arose, it served as a template for further duplications. Because of the way gene copies were arranged on the chromosomes, a process called crossing over was possible, in which DNA from two copies could mingle and copy itself.

This process explains how some populations came to have considerably more copies of the gene, while others suffered deletions. “The moment we have the three-copy haplotype, it’s the steppingstone for the evolution of this locus-we can either go up by two copies or we can go down by two,” says Charikleia Karageorgiou, a postdoctoral researcher and co-author on the study.

 

Implications for Evolutionary Biology

The revelation of duplication mechanisms of the AMY1 gene provides a wider understanding of how structural variations in the genome contribute to human evolution. “These findings are very exciting,” says Diyendo Massilani, a geneticist at Yale University, who adds that it could spur further research into how gene copy number variations have driven human adaptation. This research could also yield some clues toward understanding other genetic conditions related to gene copy number, such as Huntington’s disease.

This ability to digest starch more effectively has clearly been a valuable trait for humans over the millennia, helping to fuel the rise of agriculture and to support growing populations. And as researchers continue to unravel the many complexities in our evolutionary history, it would seem genes like AMY1 have played a very important role in shaping who we are today.

 

Conclusion

The evolution of the AMY1 gene and this starch digestion superpower give an exciting glimpse into the dynamics of human adaptability. With the timeline of duplication of AMY1 still under debate, one thing is for sure: such a genetic trait has played an important role in human survival and dietary evolution. From the first mutations that allowed early humans to digest starch a little better, through the agricultural revolution that multiplied AMY1 gene copies manyfold, this genetic story is one of resilience and adaptation.

As researchers continue to learn more about the subject, we piece together a complex puzzle of just how our ancestors evolved to develop the tools needed for them to thrive on a diet based on starchy foods, a capability that shaped human history.

At AHB Lab, we’re committed to keeping you informed on these crucial developments and their impact on our industry. Stay tuned for more insights as the election progresses!

Leave a Reply

Your email address will not be published. Required fields are marked *

公司最新訊息

ICPPX® 透皮黑科技:喚醒自體修復的關節筋膜指南

真正喚醒身體自癒力的解決方案 面對關節僵硬、肩頸痠痛、足底筋膜炎,或是運動後的肌腱發炎,多數人是否已經習慣吞下止痛藥、敷上冰袋,或是定期到診所施打玻尿酸 ? 在生物醫學與抗衰老領域中,我們經常看到消費者陷入一個無止盡的迴圈:疼痛 ➡️ 抑制痛覺 ➡️ 暫時舒緩 ➡️ 再次發炎。這是因為傳統的醫療手段,往往只能帶來短暫的舒緩 。這篇文章將帶您從微觀的「生技醫學」視角,徹底揭開傳統保養的生理限制 ,並為品牌主與研發人員介紹一項能真正喚醒身體自癒力的新興胜肽(Peptides)解決方案 。   為何常規治療只是在「拖延時間」? 在探討胜肽科技之前,我們必須先釐清現有市場方案的盲點。傳統的關節與筋膜保養,很多時候只是在欺騙大腦與拖延時間 : 止痛藥與肌肉鬆弛劑(剪斷警報器):吞下非類固醇消炎止痛藥(NSAIDs),就像是房子著火了,你卻拿剪刀把狂響的「火災警報器」電線給剪斷 。藥物阻斷了痛覺神經,但深層組織裡的發炎大火不僅沒熄滅,甚至正越燒越旺,持續吃掉軟骨與肌腱 。  玻尿酸注射(漏水的水桶):人體內本來就存在「透明質酸酶」會自然代謝外來物 。施打外來玻尿酸,就像把水倒進一個底部有裂縫的水桶,水分終究會流失 。  冰敷與涼感貼布(延緩修復):低溫會強制收縮血管,等於在傷口外圍拉起封鎖線,把帶來氧氣與修復細胞的「救援部隊」擋在門外,反而延緩了真實的修復進度 。 

Read More
公司最新訊息

關節退化只能等著開刀?揭開常規止痛藥無效的兩大微觀真相與胜肽修復新趨勢

為什麼吃遍止痛藥,關節依然隱隱作痛? 當你吃盡各種止痛藥、試過無數次物理治療,關節與肩頸的疼痛卻依然如影隨形時,你或許會開始懷疑,難道是自己的身體真的「壞掉」了嗎 ? 大多數人面對關節僵硬與疼痛時,總以為這只是一種無可避免的「生理性磨損」 。面對這類困擾,我們習慣依賴常規的口服消炎藥或肌肉鬆弛劑來尋求微乎其微的短暫舒緩感 。然而,問題並不是你的修復能力消失了,而是你一直沒有揪出潛伏在身體深處的真正破壞者 。 今天,我們將帶你潛入微觀的細胞世界,揭開導致關節退化與筋膜反覆發炎、長久難以痊癒的兩大核心元凶 ,並探討為何「胜肽(Peptides)」這項先進的生物科技解決方案,正成為替代傳統低效消耗戰的未來趨勢。   揪出元凶:微觀世界裡的兩大破壞者 如果我們把你隱隱作痛的部位放在顯微鏡下觀察,你會看到一場令人毛骨悚然的細胞大火 。這正是導致你久病不癒的兩大核心痛點: 元凶一:細胞內的隱形野火(TNF-α 與 IL-1β) 當關節受損時,免疫系統會釋放出一群極度凶狠的促發炎因子,也就是惡名昭彰的 TNF-α 與 IL-1β 。 你可以把這兩個恐怖分子想像成極具腐蝕性的「體內硫酸」,它們正日以繼夜地侵襲、溶解你的關節軟骨與肌腱組織 。 這場大火會把負責製造軟骨與潤滑液的細胞「強制斷電」,逼迫軟骨細胞與纖維母細胞進入深度的休眠與罷工狀態 。只要細胞內的隱形野火一天不撲滅,軟骨自然無法得到重建

Read More
公司最新訊息

為什麼傳統消炎藥無法根治痠痛?揭秘「關健膠原肽療法」如何從源頭重啟肌腱筋膜修復力

當止痛藥成為一種無奈的妥協 現代人生活節奏緊湊,無論是長時間久坐辦公室盯著電腦,還是週末為了釋放壓力而瘋狂運動,你是否經常感到肩頸僵硬、手肘隱隱作痛,或是早晨剛下床踩地時,腳底傳來一陣刺痛 ?這些看似平常卻惱人的症狀,很可能正是「肌腱炎」或「筋膜炎」在向你發出警訊 。 以上的肌腱或是筋膜的警訊如 : 一、肌腱問題(例如:肌腱炎)的常見症狀 常見於手肘、肩膀、膝蓋、腳踝等部位: 🔹 1. 局部疼痛 活動時加劇(例如拿東西、走路、抬手)  靜止時可能減輕,但嚴重時會持續疼痛  🔹 2. 壓痛 用手按壓某條肌腱會明顯疼痛  🔹 3. 僵硬感 早上起床或久坐後特別明顯  活動後稍微改善  🔹 4. 無力或功能下降

Read More